The global tumor ablation market is expected to grow from USD 0.8 billion in 2024 to USD 1.4 billion by 2029, expanding at a CAGR of 10.0% over the forecast period. This substantial growth is driven by technological advancements, new product developments—particularly in cryoablation—and the rising incidence of cancer worldwide. As a minimally invasive treatment option, tumor ablation continues to gain popularity for its effectiveness in treating various cancer types.
Download an Illustrative overview:
Key Drivers of Growth
- Technological Advancements in Tumor Ablation Technologies Innovation in tumor ablation technologies such as radiofrequency (RF), microwave, laser, irreversible electroporation (IRE), high-intensity focused ultrasound (HIFU), and cryoablation is boosting market growth. These advancements have improved the safety, precision, and efficacy of tumor ablation procedures, making them more appealing to both physicians and patients.
- New Product Developments in Cryoablation Cryoablation technology, which uses extreme cold to destroy cancerous tissues, has seen significant improvements. New products and devices are enhancing the accuracy and success of this treatment method, which is particularly useful in treating cancers such as liver, lung, and bone tumors.
- Rising Incidence of Cancer The global increase in cancer cases is a critical factor driving demand for tumor ablation procedures. Tumor ablation offers a less invasive alternative to surgery, with fewer complications and quicker recovery times, which is making it an increasingly popular treatment option.
Market Segmentation
Technology: The market is segmented into radiofrequency, microwave, laser, irreversible electroporation (IRE), high-intensity focused ultrasound (HIFU), and cryoablation technologies. Among these, radiofrequency and cryoablation are currently the most widely used techniques.
Products: The tumor ablation market includes generators and probes, which are essential components of the ablation process. Continuous product innovation and development in this segment are key to market expansion.
Modes of Treatment: Tumor ablation can be performed through surgical, laparoscopic, and percutaneous approaches. Percutaneous ablation, being minimally invasive, is gaining more traction due to its lower complication rates and faster recovery times.
Cancer Types: Tumor ablation is primarily used for treating cancers of the liver, lung, and bone, with liver cancer being one of the most common types treated with this method.
End Users: Major end users of tumor ablation technologies include hospitals and clinics, where these procedures are typically performed. The demand for these technologies is increasing across healthcare settings, driven by the need for more efficient, less invasive cancer treatments.
Conclusion
The tumor ablation market is on a path of robust growth, driven by technological innovations, increasing cancer cases, and new product developments in cryoablation. As the market is set to reach USD 1.4 billion by 2029, healthcare providers are expected to adopt these advanced technologies at an accelerated rate, offering patients safer and more effective cancer treatment options. The shift toward minimally invasive procedures will continue to play a significant role in the market's expansion.
Content Source:
https://www.marketsandmarkets.com/PressReleases/tumor-ablation.asp
https://www.marketsandmarkets.com/ResearchInsight/tumor-ablation-market.asp
